CCRN
Cross Country Healthcare, Inc.NASDAQHealthcare$9.18-1.50%ClosedMarket Cap: $296.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.95
P/S
0.29
EV/EBITDA
15.10
DCF Value
$24.85
FCF Yield
13.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
18.7%
Operating Margin
-0.3%
Net Margin
-9.0%
ROE
-24.3%
ROA
-21.1%
ROIC
-0.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $236.8M | 13.2% | $9.3M | $-82.9M | $-2.56 | — |
| FY 2025 | $1.05B | 18.7% | $-3.5M | $-94.9M | $-2.93 | — |
| Q3 2025 | $250.1M | 20.4% | $-6.0M | $-4.8M | $-0.15 | — |
| Q2 2025 | $274.1M | 20.4% | $-5.9M | $-6.7M | $-0.20 | — |
| Q1 2025 | $293.4M | 20.0% | $-977.0K | $-490.0K | $-0.02 | — |
| Q4 2024 | $309.9M | 20.0% | $-3.4M | $-3.8M | $-0.12 | — |
| FY 2024 | $1.34B | 20.4% | $-16.9M | $-14.6M | $-0.44 | — |
| Q3 2024 | $315.1M | 20.4% | $2.9M | $2.6M | $0.08 | — |
| Q2 2024 | $339.8M | 20.8% | $-19.2M | $-16.1M | $-0.47 | — |
| Q1 2024 | $379.2M | 20.4% | $2.9M | $2.7M | $0.08 | — |
| Q4 2023 | $414.0M | 21.9% | $13.4M | $9.0M | $0.26 | — |
| FY 2023 | $2.02B | 22.3% | $112.7M | $72.6M | $2.05 | — |